used in traditional Chinese, Ayurvedic, and Thai drugs. Conolidine could represent the start of a brand new era of Continual pain management. It is currently remaining investigated for its results on the atypical chemokine receptor (ACK3). In a very rat model, it was identified that a competitor molecule binding to ACKR3 resulted in inhibition of A